Drug Series

Please register below to view the latest Touch Briefings report on Drug Series

The Drug series enables time-pressured professionals to stay abreast of key advances and trends from across the discovery, development and delivery landscapes. Comprising commentaries, editorials and review articles written by respected thought-leaders in each specialist area, the Drug series aims to assist pharmaceutical and biotechnology professionals in continuously developing their knowledge and productivity.

Guided by Advisory Boards consisting of industry leaders, the Drug series seeks to disseminate best practice through the entire drug chain – from initial discovery through to delivery. With expert opinion on the most salient topics and challenges facing the industry, the Drug series' pan-regional focus provides a truly global perspective, encouraging informed discussion among key peer groups.

* Please note all fields are mandatory